{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:27:00Z","timestamp":1760549220105,"version":"3.44.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.ando.2007.06.010","type":"journal-article","created":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T23:18:09Z","timestamp":1329952689000},"page":"220-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Expanding use of\u00a0recombinant hTSH"],"prefix":"10.1016","volume":"68","author":[{"given":"L.","family":"Fugazzola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2007.06.010_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/jc.2003-031027","article-title":"Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma","volume":"89","author":"Chin","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.06.010_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1365-2265.2003.01830.x","article-title":"Recombinant human TSH testing is a valuable tool for differential diagnosis of congenital hypothyroidism during L-thyroxine replacement","volume":"59","author":"Fugazzola","year":"2003","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ando.2007.06.010_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-007-0377-6","article-title":"Thyroid scintigraphy and perchlorate test after recombinant human TSH in paediatric age: a new tool for the differential diagnosis of congenital hypothyroidism during L-thyroxine replacement therapy","author":"Fugazzola","year":"2007","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ando.2007.06.010_bib4","first-page":"3877","article-title":"Comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer","volume":"84","author":"Haugen","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.06.010_bib5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/bmj.297.6649.661","article-title":"Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goiter","volume":"297","author":"Hegedus","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.ando.2007.06.010_bib6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-121-10-199411150-00005","article-title":"Large, compressive goiters treated with radioiodine","volume":"121","author":"Huysman","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ando.2007.06.010_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/nm.2000.4599","article-title":"Recombinant thyrotropin versus thyroid hormone withdrawal in evaluating patients with thyroid carcinoma","volume":"30","author":"Ladenson","year":"2000","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.ando.2007.06.010_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1530\/eje.0.1440005","article-title":"Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH","volume":"144","author":"Lippi","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ando.2007.06.010_bib9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1089\/thy.2000.10.767","article-title":"Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions","volume":"10","author":"Mazzaferri","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2007.06.010_bib10","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1210\/jc.2002-021554","article-title":"Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodide therapy in patients with nodular goiter","volume":"88","author":"Nieuwlaat","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.06.010_bib11","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/bmj.307.6908.828","article-title":"Radioiodine treatment of multinodular non-toxic goiter","volume":"307","author":"Nygaard","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.ando.2007.06.010_bib12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1210\/jc.2005-1651","article-title":"Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study","volume":"91","author":"Pacini","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.06.010_bib13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00259-001-0745-6","article-title":"Influence of rhTSH on [(18)F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma","volume":"29","author":"Petrich","year":"2002","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ando.2007.06.010_bib14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/jcem.86.2.7189","article-title":"Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma","volume":"86","author":"Robbins","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.06.010_bib15","first-page":"1482","article-title":"A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation","volume":"43","author":"Robbins","year":"2002","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ando.2007.06.010_bib16","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1210\/jc.2001-011151","article-title":"Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer","volume":"87","author":"Santini","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.06.010_bib17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-2265.2003.01918.x","article-title":"Administration of a single dose of recombinant human thyrotropin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres","volume":"60","author":"Silva","year":"2004","journal-title":"Clin Endocrinol"},{"issue":"Suppl","key":"10.1016\/j.ando.2007.06.010_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1651-2227.1999.tb01147.x","article-title":"Guidelines for neonatal screening programs for congenital hypothyroidism. Working Group for Neonatal Screening in Paediatric Endocrinology of the European Society for Paediatric Endocrinology","volume":"88","author":"Toublanc","year":"1999","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ando.2007.06.010_bib19","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00259-005-1818-8","article-title":"Radioiodine treatment of non-toxic multinodular goitre: effects of combination with lithium","volume":"32","author":"Vannucchi","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ando.2007.06.010_bib20","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/jcem.86.3.7244","article-title":"A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic non-toxic goiter","volume":"86","author":"Wesche","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426607001503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426607001503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:43:11Z","timestamp":1757716991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426607001503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0003426607001503"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2007.06.010","relation":{},"ISSN":["0003-4266"],"issn-type":[{"type":"print","value":"0003-4266"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding use of\u00a0recombinant hTSH","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2007.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}